Difference between revisions of "Extramammary Paget disease"

Jump to navigation Jump to search
Line 37: Line 37:
Panel:
Panel:
*CEA +ve (-ve in Bowen's disease, -ve in Toker cells).
*CEA +ve (-ve in Bowen's disease, -ve in Toker cells).
*CK7 +ve. (???)
*CK7 +ve.
**Toker cells CK7 +ve.<ref name=pmid19601945>{{Cite journal  | last1 = Nofech-Mozes | first1 = S. | last2 = Hanna | first2 = W. | title = Toker cells revisited. | journal = Breast J | volume = 15 | issue = 4 | pages = 394-8 | month =  | year =  | doi = 10.1111/j.1524-4741.2009.00743.x | PMID = 19601945 }}</ref>
**Toker cells CK7 +ve.<ref name=pmid19601945>{{Cite journal  | last1 = Nofech-Mozes | first1 = S. | last2 = Hanna | first2 = W. | title = Toker cells revisited. | journal = Breast J | volume = 15 | issue = 4 | pages = 394-8 | month =  | year =  | doi = 10.1111/j.1524-4741.2009.00743.x | PMID = 19601945 }}</ref>
*S100 -ve, HMB-45 -ve (both typically +ve in melanoma).
*S100 -ve, HMB-45 -ve (both typically +ve in melanoma).
Line 45: Line 45:
*CK5/6 -ve.<ref>RS. May 2010.</ref>
*CK5/6 -ve.<ref>RS. May 2010.</ref>
**Usu. +ve in [[squamous cell carcinoma]].
**Usu. +ve in [[squamous cell carcinoma]].
*CAM 5.2 +ve.


==See also==
==See also==
48,830

edits

Navigation menu